Get the Stockscreener App
158.92
1.64%
2.56
After Hours:
158.92
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $158.92, with a volume of 1.31M.
It is up +1.64% in the last 24 hours and up +1.92% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$156.36
Open:
$157.09
24h Volume:
1.31M
Relative Volume:
0.49
Market Cap:
$43.79B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
40.30
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+2.87%
1M Performance:
+1.92%
6M Performance:
-21.87%
1Y Performance:
-14.25%
1-Day Range:
$157.09
$160.55
1-Week Range:
$151.97
$160.55
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
247,240 Shares in Becton, Dickinson and Company $BDX Purchased by Luxor Capital Group LP - MarketBeat
Public Employees Retirement System of Ohio Raises Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Sei Investments Co. Purchases 36,488 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
71,000 Shares in Becton, Dickinson and Company $BDX Bought by Archon Partners LLC - MarketBeat
US075887BG35 Bond Profile — Key Metrics - TradingView
Becton, Dickinson and Co (BDX) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Becton, Dickinson and Co (BDX) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Becton Dickinson and Co (BDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Becton Dickinson and Co (BDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Becton Dickinson and Co (BDX) Institutional Confidence - TradingKey
BDX|Becton Dickinson and Co|Price:159.812|Chg%:+3.452 - TradingKey
Becton Dickinson and Co (BDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BDX|Becton Dickinson and Co|Price:156.350|Chg%:+3.380 - TradingKey
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies - GlobeNewswire Inc.
BDX|Becton Dickinson and Co|Price:152.940|Chg%:-0.220 - TradingKey
Clarkston Capital Partners LLC Sells 235,144 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson and Co (BDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Levin Capital Strategies L.P. Has $22.60 Million Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson and Co (BDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Becton, Dickinson and Co (1BDX) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Becton, Dickinson and Co (1BDX) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Becton, Dickinson and Company (BDX) Announces Executive Retireme - GuruFocus
BD Executive Mike Garrison to Retire After More Than 20 Years - citybiz
Becton, Dickinson and Company (BD) 8-K Filing: Company Overview, Key Contacts, and NYSE Listing Information - Minichart
SEB Asset Management AB Invests $9.74 Million in Becton, Dickinson and Company $BDX - MarketBeat
Dimensional Fund Advisors LP Lowers Holdings in Becton, Dickinson and Company $BDX - MarketBeat
A3LD4N Bond Profile — Key Metrics - TradingView
US75887BG3 Bond Profile — Key Metrics - TradingView
Glenview Trust Co Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Hahn Capital Management LLC Has $5.87 Million Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 13.4% Potential Upside Amid Strong Healthcare Performance - DirectorsTalk Interviews
Hsbc Holdings PLC Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
A3LUHG Bond Profile — Key Metrics - TradingView
Assetmark Inc. Has $55.89 Million Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Friday when compared to competitors - MarketWatch
Becton Dickinson (BDX) Stock Looks Cheap On Cash Flow Yet Fair On Earnings - simplywall.st
Becton Dickinson & Co (BDX) Shares Surge 3.3% -- What GF Score o - GuruFocus
Becton Dickinson stock holds steady as medical technology demand underpins long-term growth - AD HOC NEWS
Marks Group Wealth Management Inc Acquires 9,363 Shares of Becton, Dickinson and Company $BDX - MarketBeat
A3LUDB Bond Profile — Key Metrics - TradingView
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
BDX.GE Bond Profile — Key Metrics - TradingView
Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating - Moomoo
US75887CK3 Bond Profile — Key Metrics - TradingView
XS276302639 Bond Profile — Key Metrics - TradingView
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $175 - 富途牛牛
XS283900436 Bond Profile — Key Metrics - TradingView
Becton, Dickinson and Company (BDX) Stock Analysis: A 16% Upside Opportunity in the Healthcare Sector - DirectorsTalk Interviews
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.45%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):